Murphy Oil Corporation Stock News

Murphy Oil Co. (NYSE:MUR) – Research analysts at Piper Sandler increased their Q2 2020 earnings per share estimates for Murphy Oil in a research report issued on Wednesday, April 1st. Piper Sandler

Murphy Oil Co. (NYSE:MUR) – Analysts at Capital One Financial dropped their Q1 2020 earnings estimates for Murphy Oil in a report issued on Thursday, April 2nd. Capital One Financial analyst B. Veli

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Im

Bank of America Corp DE raised its holdings in shares of Murphy Oil Co. (NYSE:MUR) by 3.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. T

Murphy Oil Co. (NYSE:MUR) – Analysts at KeyCorp reduced their Q4 2021 EPS estimates for Murphy Oil in a research report issued to clients and investors on Wednesday, April 1st. KeyCorp analyst L. Ma

Murphy Oil Co. (NYSE:MUR) – Research analysts at Capital One Financial issued their FY2021 earnings estimates for shares of Murphy Oil in a research report issued on Thursday, April 2nd. Capital One

Murphy Oil (NYSE:MUR) had its target price cut by UBS Group from $27.00 to $5.50 in a research report released on Tuesday, BenzingaRatingsTable reports. They currently have a neutral rating on the oil

TOTAL (TOT) and its joint venture partner Apache discover more oil in Block 58 offshore Suriname.

TOTAL (TOT) and its joint venture partner Apache discover more oil in Block 58 offshore Suriname.

Capricor Therapeutics (NASDAQ:CAPR) +26% on providing its CAP-1002 cell therapy under compassionate use for patients with advanced COVID-19.Fate Therapeutics (NASDAQ:FATE) +19% on J&J cell therapy

Murphy Oil downgraded to Underperform from Neutral at Mizuho Mizuho MUR

Murphy Oil (NYSE:MUR)‘s stock had its “buy” rating restated by research analysts at Wells Fargo & Co in a report released on Friday, AnalystRatings.com reports. Several other analysts have also

Wells Fargo analyst Roger Read maintained a Buy rating on Murphy Oil (MUR) today. The company's shares closed last Thursday at $6.23, close to its 52-week